Wedbush Decreases Earnings Estimates for Ovid Therapeutics
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Analysts at Wedbush decreased their Q2 2025 earnings per share estimates for Ovid Therapeutics in a research report issued on Tuesday, May 13th. Wedbush analyst L. Chico now forecasts that the company will post earnings per share of ($0.16) for the quarter, down from their prior forecast […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Analysts at Wedbush decreased their Q2 2025 earnings per share estimates for Ovid Therapeutics in a research report issued on Tuesday, May 13th. Wedbush analyst L. Chico now forecasts that the company will post earnings per share of ($0.16) for the quarter, down from their prior forecast […]
